Coordinating research into cancer precision prevention and early detection at the University of Oxford. Former yeast molecular geneticist. Views my own.
"We now know that cancer does not come from nowhere."
Prof Sarah Blagden, director of a new research collaboration between pharma giant GSK and the University of Oxford, tells #R4Today about the development of a new 'pre-cancer' vaccine that could target the disease earlier.
It’s hard to believe that OxCODE has been going for 5 years already!
We’re celebrating with a 2-day symposium of talks, panel discussions, posters and networking. Looking forward to some excellent science!
#oxcode24@OxfordCancer
🚀The wait is over: registration is open for our second annual Cancer Prevention Research Conference! Get your ticket & join us in London to discuss the latest concepts in cancer prevention research.
Register today: https://t.co/c5KZ9oKbzD
#PrevConf25 | @AmericanCancer
Our latest episode explores research that identified 250+ genes that play a crucial role in bowel cancer, offering hope for prevention, screening and targeted treatments. Tune in as our guests discuss the findings and their impact 🎙️
Listen here: https://t.co/O3VwVz4rho
💡 Jens Rittscher (@JensRittscher) is leveraging AI to analyze endoscopy images for Barrett’s esophagus. 🤖🔬
His lab focuses on automated quantification for data-driven phenotyping, with exciting potential to extend into spatial transcriptomics and thicker tissue slices—advancing biomarker discovery. 🧬📊
#AIinMedicine #Endoscopy #ImageAnalysis #BarrettsEsophagus
#EDxConf24 | @CRUKresearch | @OHSUKnight | @UniofOxford
-pds
Oxford Centre for Cancer Early Detection and Prevention Symposium
10-11th December, Oxford
Keynote speakers: Victor Velculescu @JohnsHopkins, Sam Janes @uclmedsci, Molly Stevens @KavliOxford and @GeorgiaBBlack@QMUL_WIPH
Abstracts due: 8th Nov
Register ⬇️
https://t.co/ho1NrPRgrG
'Thanks to this funding, our research can take a big step forward towards a viable vaccine for ovarian cancer.'
Professor Ahmed Ahmed @MRC_WIMM comments on new funding from @CRUKresearch to create the world’s first vaccine to prevent #OvarianCancer. 👇
https://t.co/aSlglAltPN
#InTheNews We’ve awarded researchers at the @UniofOxford up to £600,000 to create the world’s first vaccine to prevent ovarian cancer.
OvarianVax is a vaccine that will teach the immune system to recognise and attack the earliest stages of ovarian cancer.
After winning #PrevConf24 poster prize, Zhe Huang (@UniofOxford) talked to us about his work on investigating the proteomic profiles of #ProstateCancer, his trip to Boston and the story behind his early career.
Read more👇
David Church & Simon Leedham will use a Biology to Prevention Award to work on a precision prevention vaccination strategy for Lynch syndrome. They will define candidate frameshift peptides and determine mechanisms of immune escape.
@leedham_simon | @UniofOxford | #CRUKFundeDavid Church & Simon Leedham will use a Biology to Prevention Award to work on a precision prevention vaccination strategy for Lynch syndrome. They will define candidate frameshift peptides and determine mechanisms of immune escape.
@leedham_simon | @UniofOxford | #CRUKFunded
Exciting progress for those of us with Lynch syndrome! As 1 of 4 in the PPI group contributing to this research, it’s brilliant that the researchers have listened to us. A potential vaccine that could prevent not just bowel cancer, but also womb cancer! 🙌#LynchSyndrome#PPI
And huge congratulations to @HollyEggington for being the best early career researcher poster prize winner for the mechanistic theme!
A very worthy recipient of one of this year’s OxCODE travel awards!
@OxfordCancer#PrevConf24
Special lecture from Sir Richard Peto @Oxford_NDPH (summarised by Sir John Burn) acknowledging the 70th anniversary of the discovery of the link between smoking and cancer in Oxford
#PrevConf24@OxfordCancer